Work Here?
Overview
BioPhorum is a B2B membership organization that enables collaboration across global biopharmaceutical and medical device industries. It provides a non-competitive space where leaders and experts tackle shared challenges, define best practices, and advance projects through focused forums called Phorums. Members from license holders, manufacturers, CDMOs, and suppliers work on industry-wide initiatives to improve operations, reduce costs, and streamline regulatory processes, plus tools like the Digital Plant Maturity Model (DPMM) to guide digital transformation. Its goal is to accelerate progress in biopharma and medical device manufacturing by sharing knowledge, setting industry-wide practices, and improving efficiency and regulatory readiness.
About BioPhorum
Industries
Data & Analytics
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2008
Get referred to BioPhorum
See people who can refer or advise you
Simplify's Take
What believers are saying
- BioPhorum deepened monetization with subscription HCP data and flexible pricing in June 2026.
- Regulators MHRA, British Pharmacopoeia, and USP joined its July 2026 small-molecule initiative.
- PharmaX acquisition converts BioPhorum insights into implementation services for manufacturers.
What critics are saying
- Recent acquisitions of PharmaX, Inspired Pharma, and Compliance Hub complicate integration.
- Training and consulting expansion dilutes the pure-membership model by 2026.
- Pharma giants can internalize collaboration forums, shrinking BioPhorum’s relevance by 2028.
What makes BioPhorum unique
- BioPhorum convened 20 organizations on synthetic molecules in July 2026.
- Its 2026 advisory board includes Pfizer, GSK, Eli Lilly, and Merck.
- BioPhorum’s HCP platform offers 300 risk-assessed proteins with API integration.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 5%1 year growth
↑ 5%2 year growth
↑ 5%/PRNewswire/ -- BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions...
BioPhorum, a pharmaceutical industry collaborative network, has announced the formation of its inaugural Strategic Advisory Board comprising 14 senior executives from major pharmaceutical companies. The board will provide executive guidance on critical industry challenges including global regulation, new technology and supply chain resilience. Members include executives from Pfizer, GSK, Eli Lilly, Amgen, Sanofi, Merck, SK Pharmteco, Fujifilm BioTechnologies, eXmoor, Sartorius, UCB and Cytiva. The board will serve as a forum for strategic dialogue on pressing industry-wide challenges and opportunities. BioPhorum CEO Deborah Kobewka described the board's launch as "a defining milestone", noting that executive-led direction is crucial as the industry navigates volatility and a challenging global investment landscape. The board aims to help members turn market complexity into a shared roadmap for sustainable growth.
Media Release 17 December 2025 BioPhorum acquires Inspired Pharma to enhance its training and support for pharmaceutical professionals worldwide Strategic acquisition strengthens BioPhorum’s ability to deliver insight, expertise, and practical solutions to its global membership and life sciences client community across the pharmaceutical value chain BioPhorum is pleased to announce the acquisition of Inspired Pharma, a leading provider of specialist training for the...
19 May 2025London, UKBioPhorum, the global organisation accelerating collaboration between biopharmaceutical and medical device industry leaders, is pleased to announce the appointment of Dr. Uwe Buecheler, as Non-Executive Director (NED) to its Board of Directors, effective May 19, 2025.Dr. Buecheler brings a wealth of experience and expertise in the biopharmaceutical industry, having held various leadership roles in development operations, strategic planning, and innovation. He has overseen more than 30 biologics launches, including several top global biopharmaceuticals and has held senior roles in regulatory affairs, CMC development, biosafety, quality, CDMO business and operations.Dr. Buecheler led the expansion of Boehringer Ingelheim's Global Operations Network in the US and China and pioneered the first Biologics MAH approval in Shanghai. He also contributed to major expansion projects in aseptic processing, microbial manufacturing, and large-scale mammalian cell culture operations
BioPhorum acquires training organisation Brookwood Global.
BioPhorum is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today
About BioPhorum
Industries
Data & Analytics
Consulting
Industrial & Manufacturing
Biotechnology
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2008
BioPhorum is Hiring for 5 Jobs on Simplify!
Find jobs on Simplify and start your career today